Utility of heparin-binding protein following cardiothoracic surgery using cardiopulmonary bypass
Abstract Cardiothoracic surgery using cardiopulmonary bypass (CPB) triggers an inflammatory state that may be difficult to differentiate from infection. Heparin-binding protein (HBP) is a candidate biomarker for sepsis. As data indicates that HBP normalizes rapidly after cardiothoracic surgery, it m...
Main Authors: | Emilia Johannesson, Clara Erixon, Niklas Sterner, Louise Thelaus, Alain Dardashti, Johan Nilsson, Sigurdur Ragnarsson, Adam Linder, Igor Zindovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-48457-y |
Similar Items
-
Heparin Coating Technology in Cardiopulmonary Bypass
by: Zhang Kun, et al.
Published: (2017-01-01) -
Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
by: Emre Boysan, et al.
Published: (2023-09-01) -
Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
by: Parissis Haralabos
Published: (2011-04-01) -
Heparin binding protein in severe COVID-19-A prospective observational cohort study.
by: Lisa Mellhammar, et al.
Published: (2021-01-01) -
Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model /
by: Walenga, J. M.